LASSBio-1425

N/A

Report date: 2023/03/25 23:35:15
NME

Base Information

Drug NameLASSBio-1425
Drug Alias NameLASSBio-1425
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsHypertriglyceridemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversidade Federal Fluminense
China Registration ClassN/A

Develop Information

Active CompaniesUniversidade Federal Fluminense
Inactive CompaniesN/A
Active IndicationsHypertriglyceridemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A